Press Releases for PPDI

Press Releases
PPD Declares Fourth Quarter Dividend
PPD Declares Third Quarter Dividend
PPD Named One of North Carolina’s Best Employers
PPD Reports Second Quarter 2009 Financial Results
BenchmarkJournal.Com Free Analyst Review for PCBC, SHLD, PPDI, SOHU, AMMD and TSTR
PPD Announces Second Quarter 2009 Earnings Release, Webcast and Conference Call
PPD Confirms Takeda Receives FDA Complete Response for Alogliptin
PPD Confirms Johnson & Johnson Pharmaceutical Research & Development’s Completion of Additional Phase III Studies Providing Expanded Safety and Efficacy Data for Priligy®
PPD Announces Takeda to Conduct Additional Study for Alogliptin MAA in the EU
PPD Increases Cash Dividend Rate for Fourth Consecutive Year; Declares Second Quarter Dividend
PPD Promotes Fred Eshelman to Executive Chairman; Ernest Mario Assumes Role of Lead Independent Director; PPD Names David Grange as New Chief Executive Officer
PPD’s Global Central Lab in Beijing Earns CAP Accreditation
PPD Reports First Quarter 2009 Financial Results; Updates 2009 Financial Guidance
PPD Completes Acquisition of AbCRO
PPD Opens Office in Tokyo, Japan
AnalystChoice.Com Free Investment Opinion on PPDI, MEDX, CVTX and OSIP
PPD Acquires Magen BioSciences
PPD to Divest Piedmont Research Center
PPD Announces First Quarter 2009 Earnings Release, Webcast and Conference Call
PPD Updates Discovery Segment Guidance Regarding Alogliptin
PPD Declares First Quarter Dividend
PPD to Receive Milestone Payments for First Regulatory Approvals of Priligy™ (Dapoxetine) in Finland and Sweden for Treatment of Premature Ejaculation
PPD Reports Fourth Quarter and Full Year 2008 Financial Results
PPD to Acquire AbCRO
PPD Announces Fourth Quarter and Full-Year 2008 Earnings Release, Webcast and Conference Call
PPD Issues 2009 Financial Guidance
PPD Expands Post-Approval Drug Safety Capabilities through Strategic Alliance with WHISCON
PPD to Present at 27th Annual J.P. Morgan Healthcare Conference
PPD Enters Into Strategic Collaboration with Merck
PPD to Expand Contract Research Operations into Ireland
PPD to Expand Global Central Lab Services into Singapore
PPD Announces Inclusion in NASDAQ-100 Index®
PPD Announces Inclusion in NASDAQ-100 Index®
NASDAQ Announces the Annual Re-Ranking of the NASDAQ-100 Index
PPD Announces 2009 Financial Guidance Webcast and Conference Call
PPD Declares Fourth Quarter Dividend
PPD Chairman of the Board Pledges $5 Million to Rutgers' Ernest Mario School of Pharmacy
PPD Reports Third Quarter 2008 Financial Results; Updates 2008 Financial Guidance
FDA to Continue Review of Alogliptin NDA
CSS Informatics Partners with DrugLogic(R) to Offer Clients Faster Access to Clinical Trial Adverse Event Data
PPD Selected as Clinical Development Preferred Provider by Juvenile Diabetes Research Foundation
BetterInvesting Magazine Releases December's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use
PPD Announces Third Quarter 2008 Earnings Release, Webcast and Conference Call
PPD Completes Acquisition of InnoPharm
PPD Confirms Takeda's NDA Submission of Alogliptin in Japan
PPD Confirms Takeda's NDA Submission of Alogliptin and ACTOS(R) to U.S. Food and Drug Administration
PPD Increases Cash Dividend
PPD Declares Third Quarter Dividend
PPD Reports Second Quarter 2008 Financial Results
PPD Names Christine Dingivan, M.D., Executive Vice President and Chief Medical Officer
PPD Announces Second Quarter 2008 Earnings Release, Webcast and Conference Call
PPD Accelerates Clinical Trial Data Collection and Reporting With Oracle(R) Remote Data Capture 4.5.3
PPD Launches Innovative Web-based Technology to Analyze Near Real-time Global Central Lab Data
PPD Opens Office in Istanbul, Turkey
CSS Informatics Releases eLoader(TM) 4.0
PPD Declares Second Quarter Dividend - Jun 1 2008 4:46AM
PPD Declares Second Quarter Dividend - May 27 2008 12:17AM
PPD Enhances its Portfolio of EDC Services with Oracle(R) Remote Data Capture Onsite 4.5.3
PPD Reports First Quarter 2008 Financial Results
PPD Earns CEO Cancer Gold Standard(TM) Accreditation
PPD to Present on Key Industry Topics at IIR CRO Partnerships
Paul Covington to Retire from PPD
PPD Announces First Quarter 2008 Earnings Release, Webcast and Conference Call